Improved ventilation of the edematous lung

Information

  • Research Project
  • 9456409
  • ApplicationId
    9456409
  • Core Project Number
    R01HL113577
  • Full Project Number
    2R01HL113577-06A1
  • Serial Number
    113577
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    2/15/2013 - 11 years ago
  • Project End Date
    5/31/2022 - 2 years ago
  • Program Officer Name
    REINECK, LORA A
  • Budget Start Date
    6/1/2018 - 6 years ago
  • Budget End Date
    5/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    06
  • Suffix
    A1
  • Award Notice Date
    1/30/2018 - 6 years ago

Improved ventilation of the edematous lung

Project Summary In the acute respiratory distress syndrome (ARDS), inflammatory lung injury increases alveolar-capillary barrier permeability. Vascular liquid floods the airspace of the lungs and causes pulmonary edema. The airspace flooding pattern is spatially heterogeneous. Patients with ARDS are treated by mechanical ventilation, which improves gas exchange but causes additional mechanical injury to the lungs that escalates over time. In particular, alveolar septa located between aerated and flooded alveoli are a site of stress concentration and the magnitude of the stress concentration is proportional to the surface tension at the air-liquid interface in flooded alveoli. Mechanical ventilation cyclically increases surface tension, thus exacerbates the stress concentrations and causes injury in the form of a sustained increase in surface tension. The sustained increase in surface tension makes mechanical ventilation yet more injurious. Thus ventilation injury escalates, with positive feedback, over time. Working in a high tidal volume lung injury model in rats, we aim to test a surface tension-lowering compound as a means of reducing the escalation of ventilation injury and to investigate the mechanism through which the compound acts.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R01
  • Administering IC
    HL
  • Application Type
    2
  • Direct Cost Amount
    296916
  • Indirect Cost Amount
    147679
  • Total Cost
    444595
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    838
  • Ed Inst. Type
    BIOMED ENGR/COL ENGR/ENGR STA
  • Funding ICs
    NHLBI:444595\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    RIBT
  • Study Section Name
    Respiratory Integrative Biology and Translational Research Study Section
  • Organization Name
    STEVENS INSTITUTE OF TECHNOLOGY
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    064271570
  • Organization City
    HOBOKEN
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    070305906
  • Organization District
    UNITED STATES